Early-phase trials lay the groundwork for every future milestone, but they’re growing more complex by the year. Lengthier protocols, higher screen failure rates, and increasing diversity requirements make clinical trial startup harder to execute and harder to get right.
In this white paper, Clinilabs outlines six proven strategies to strengthen your early-phase CNS trials from the ground up, including:
- Best practices for subject authentication, dry/wet runs, and pre-screening
- The importance of diversity in Phase 1 clinical trials
- SOPs, planning, and process enhancements that reduce protocol deviations
Whether you’re planning your first-in-human study or looking to strengthen your Phase 1 infrastructure, these insights will help you improve compliance, data quality, and efficiency from day one.
